Cargando…
Epithelial-specific ERBB3 deletion results in a genetic background-dependent increase in intestinal and colon polyps that is mediated by EGFR
ERBB3 has gained attention as a potential therapeutic target to treat colorectal and other types of cancers. To confirm a previous study showing intestinal polyps are dependent upon ERBB3, we generated an intestinal epithelia-specific ERBB3 deletion in C57BL/6-Apc(Min/+) mice. Contrary to the previo...
Autores principales: | Mantilla Rojas, Carolina, McGill, Michael P., Salvador, Anna C., Bautz, David, Threadgill, David W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659709/ https://www.ncbi.nlm.nih.gov/pubmed/34843459 http://dx.doi.org/10.1371/journal.pgen.1009931 |
Ejemplares similares
-
Prophylactic vaccination targeting ERBB3 decreases polyp burden in a mouse model of human colorectal cancer
por: Bautz, David J., et al.
Publicado: (2016) -
Differential Expression Patterns of EGF, EGFR, and ERBB4 in Nasal Polyp Epithelium
por: Duan, Chen, et al.
Publicado: (2016) -
Berry anthocyanidins inhibit intestinal polyps and colon tumors by modulation of Src, EGFR and the colon inflammatory environment
por: Mudd, Ashley M., et al.
Publicado: (2021) -
Efficacy of EGFR Inhibition Is Modulated by Model, Sex, Genetic Background and Diet: Implications for Preclinical Cancer Prevention and Therapy Trials
por: Rinella, Erica S., et al.
Publicado: (2012) -
Adding robustness to rigor and reproducibility for the three Rs of improving translational medical research
por: McGill, Michael P., et al.
Publicado: (2023)